CONTRATO POSTDOCTORAL DE INVESTIGACION SARA BORELL

Dades bàsiques

Protocol:
CD11/00007
EURDRACT:
NCT:
Centre:
Any inici:
2012
Any de finalització:
2015
RRHH NACIONAL Finan. Competitiva Pública

Objectius del projecte

FINALIZADO

Documents

  • No hi ha documents

Participants

Grups d'Investigació

Finançadors - Promotors

FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA
INSTITUTO DE SALUD CARLOS III

Resultats de l'Assaig Clínic


[Liver cell therapy in the treatment of inborn errors of metabolism in children].

Pareja E; (...); Mir J

Abstract of Published Item. 10.1016/j.anpedi.2013.05.018. 2013


A Multi-Parametric Fluorescent Assay for the Screening and Mechanistic Study of Drug-Induced Steatosis in Liver Cells in Culture.

Tolosa, Laia, Gomez-Lechon, M Jose, Donato, M Teresa

Article. 10.1002/cptx.20. 2017


A simple transcriptomic signature able to predict drug-induced hepatic steatosis

Benet M; (...); Jover R

Article. 10.1007/s00204-014-1197-7. 2014


Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems

Fernandez-Murga, ML; (...); Jover, R

Review. 10.1016/j.fct.2018.07.017. 2018


Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis

Tolosa L; (...); Donato MT

Article. 10.1016/j.taap.2016.04.007. 2016


Alternative Cell Sources to Adult Hepatocytes for Hepatic Cell Therapy.

Pareja, E, Gomez-Lechon, MJ, Tolosa, L

Article. 10.1007/978-1-4939-6506-9_2. 2017


An in vitro tool to assess cytochrome P450 drug biotransformation-dependent cytotoxicity in engineered HepG2 cells generated by using adenoviral vectors.

Lahoz A; (...); Gómez-Lechón MJ

Article. 10.1016/j.tiv.2012.08.001. 2013


Apicobasal Polarity Controls Lymphocyte Adhesion to Hepatic Epithelial Cells

Reglero-Real N; (...); Millán J

Article. 10.1016/j.celrep.2014.08.007. 2014

  • Open Access.

Assessment of the cytotoxic potential of an aqueous-ethanolic extract from Thalassia testudinum angiosperm marine grown in the Caribbean Sea.

Rodeiro, I; (...); Lopes, M

Article. 10.1111/jphp.13001. 2018

  • Open Access.

Both cholestatic and steatotic drugs trigger extensive alterations in the mRNA level of biliary transporters in rat hepatocytes: Application to develop new predictive biomarkers for early drug development

Donato MT; (...); Jover R

Article. 10.1016/j.toxlet.2016.10.008. 2016


Cellular and molecular mechanisms involved in the neuroprotective effects of VEGF on motoneurons.

Lladó J, Tolosa L, Olmos G

Article. 10.3389/fncel.2013.00181. 2013

  • Open Access.

Clinical Application of Pluripotent Stem Cells: An Alternative Cell-Based Therapy for Treating Liver Diseases?

Tolosa L, Pareja E, Gomez-Lechon MJ

Review. 10.1097/TP.0000000000001426. 2016


Comparative analysis of eight cytotoxicity assays evaluated within the ACuteTox Project.

Clothier R; (...); Stanzel S

Article. 10.1016/j.tiv.2012.08.015. 2013


Competency of different cell models to predict human hepatotoxic drugs

Gómez-Lechón MJ; (...); Donato MT

Review. 10.1517/17425255.2014.967680. 2014


Culture and Functional Characterization of Human Hepatoma HepG2 Cells.

Donato, MT, Tolosa, L, Gomez-Lechon, MJ

Article. 10.1007/978-1-4939-2074-7_5. 2015


Current status and future perspectives of hepatocyte transplantation

Pareja E; (...); Mir J

Review. 10.1016/j.ciresp.2013.04.010. 2014


Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury

Tolosa, L; (...); Teresa Donato, M.

Article. 10.1007/s00204-017-2036-4. 2018

  • Open Access.

Characterization of Proliferating Human Hepatocytes As a Model System for Drug Interaction Studies and Toxicity Screenings

Noerenberg, A; (...); Jover, R

Meeting Abstract. 2017


Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs.

Tolosa L; (...); Gómez-Lechón MJ

Article. 10.1093/toxsci/kfs083. 2012


Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: a quantitative method for oxidative stress assessment of nanoparticle-treated cells.

Aranda A; (...); Gombau L

Article. 10.1016/j.tiv.2013.01.016. 2013


Drug-induced liver steatosis and phospholipidosis: cell-based assays for early screening of drug candidates.

Donato MT, Gómez-Lechón MJ

Article. 2012


Evaluation of genotoxicity and DNA protective effects of mangiferin, a glucosylxanthone isolated from Mangifera indica L. stem bark extract.

Rodeiro I; (...); Espinosa-Aguirre JJ

Article. 10.1016/j.fct.2012.06.032. 2012


General Cytotoxicity Assessment by Means of the MTT Assay.

Tolosa, L, Donato, MT, Gomez-Lechon, MJ

Article. 10.1007/978-1-4939-2074-7_26. 2015


Hepatic cell lines for drug hepatotoxicity testing: limitations and strategies to upgrade their metabolic competence by gene engineering.

Donato MT, Jover R, Gómez-Lechón MJ

Article. 2013


Hepatocyte transplantation program: Lessons learned and future strategies

Ibars EP; (...); Mir J

Review. 10.3748/wjg.v22.i2.874. 2016

  • Open Access.

HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved.

Tolosa L; (...); Donato MT

Article. 10.1007/s00204-013-1012-x. 2013


High-content imaging technology for the evaluation of drug-induced steatosis using a multiparametric cell-based assay.

Donato MT; (...); Gómez-Lechón MJ

Article. 10.1177/1087057111427586. 2012


High-content screening of drug-induced mitochondrial impairment in hepatic cells: effects of statins

Tolosa L; (...); Donato MT

Article. 10.1007/s00204-014-1334-3. 2015


High-content screening technology for studying drug-induced hepatotoxicity in cell models

Tolosa L, Gómez-Lechón MJ, Donato MT

Review. 10.1007/s00204-015-1503-z. 2015


Human hepatocyte transplantation in patients with hepatic failure awaiting a graft.

Pareja E; (...); Mir J

Article. 10.1159/000351332. 2013


Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening

Gomez-Lechon, MJ, Tolosa, L

Review. 10.1007/s00204-016-1756-1. 2016


Human neonatal hepatocyte transplantation induces long-term rescue of unconjugated hyperbilirubinemia in the Gunn rat

Tolosa L; (...); Gómez-Lechón MJ

Article. 10.1002/lt.24121. 2015


Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing

Tolosa L; (...); Jover R

Article. 10.1093/toxsci/kfw078. 2016


Improved in vivo efficacy of clinical-grade cryopreserved human hepatocytes in mice with acute liver failure

Bolonio, M.; (...); Tolosa, L.

Meeting Abstract. 2019


Improved in vivo efficacy of clinical-grade cryopreserved human hepatocytes in mice with acute liver failure.

Donato MT; (...); Tolosa L

Article. 10.1016/j.jcyt.2019.12.005. 2020


In vitro modulation of the cytochrome P450 and ABCB1/P-glycoprotein activities of the aqueous extract of Allophylus cominia (L) Sw. leaves.

Pérez CL; (...); Rodeiro I

Article. 10.1515/dmpt-2017-0020. 2017


In vitro/in vivo screening of oxidative homeostasis and damage to DNA, protein, and lipids using UPLC/MS-MS

Carretero, A; (...); Lahoz, A

Article. 10.1007/s00216-014-7983-5. 2014


Induced pluripotent stem cells for the treatment of liver diseases: challenges and perspectives from a clinical viewpoint

Pareja, E, Gomez-Lechon, MJ, Tolosa, L

Review. 10.21037/atm.2020.02.164. 2020

  • Open Access.

LC-MS untargeted metabolomic analysis of drug-induced hepatotoxicity in HepG2 cells

García-Cañaveras JC; (...); Lahoz A

Article. 10.1002/elps.201500095. 2015


Long-term and mechanistic evaluation of drug-induced liver injury in Upcyte human hepatocytes.

Tolosa, L; (...); Donato, MT

Article. 10.1007/s00204-018-2349-y. 2019

  • Open Access.

Low density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial Hypercholesterolemia modelling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection

Caron, J; (...); Dubart-Kupperschmitt, A

Meeting Abstract. 10.1016/S0168-8278(18)30382-9. 2018


Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.

Caron J; (...); Dubart-Kupperschmitt A

Article. 10.1186/s13287-019-1342-6. 2019

  • Open Access.

Mangifera indica L. extract and mangiferin modulate cytochrome P450 and UDP-glucuronosyltransferase enzymes in primary cultures of human hepatocytes.

Rodeiro I; (...); Teresa Donato M

Article. 10.1002/ptr.4782. 2013


Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs

Gomez-Lechon, MJ, Tolosa, L, Donato, MT

Review. 10.1002/jat.3277. 2016


miR-133a regulates vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1), a key protein in the vitamin K cycle.

Pérez-Andreu V; (...); Martínez C

Article. 10.2119/molmed.2012.00062. 2013


Modelos Celulares hepáticos avanzados para el estudio preclíico del metabolismo y la hepatotoxicdad de fármacos.

MARÍA JOSÉ GÓMEZ-LECHÓN MOLINER

Article. 2017


Multiparametric evaluation of the cytoprotective effect of the Mangifera indica L. stem bark extract and mangiferin in HepG2 cells.

Tolosa L; (...); Gómez-Lechón MJ

Article. 10.1111/jphp.12071. 2013


Neonatal Livers: A Source for the Isolation of Good-Performing Hepatocytes for Cell Transplantation

Tolosa L; (...); Gómez-Lechón MJ

Article. 10.3727/096368913X669743. 2014


New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease

Lopez-Riera, M; (...); Jover, R

Article. 10.3389/fpahr.2017.00003. 2017

  • Open Access.

Predicting drug-induced cholestasis: preclinical models

Petrov, PD; (...); Jover, R

Review. 10.1080/17425255.2018.1487399. 2018


Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Godoy P; (...); Hengstler JG

Article. 10.1007/s00204-013-1078-5. 2013


Regenerative cell therapy for the treatment of hyperbilirubinemic Gunn rats with fresh and frozen human induced pluripotent stem cells-derived hepatic stem cells.

Fourrier A; (...); Nguyen TH

Article. 10.1111/xen.12544. 2020

  • Open Access.

Synthesis and cytotoxic activity of 4-N-carboxybutyl-5-fluorocytosyl-Arg-Gln-Trp-Arg-Arg-Trp-Trp-Gln-Arg-NH2.

Somlai C; (...); Enriz RD

Article. 10.1016/j.bmcl.2012.05.045. 2012


Transplantation of hESC-derived hepatocytes protects mice from liver injury

Tolosa L; (...); Dubart-Kupperschmitt A

Article. 10.1186/s13287-015-0227-6. 2015

  • Open Access.

Upgrading cytochrome P450 activity in HepG2 cells co-transfected with adenoviral vectors for drug hepatotoxicity assessment.

Tolosa L; (...); Gómez-Lechón MJ

Article. 10.1016/j.tiv.2011.11.008. 2012


Upgrading HepG2 cells with adenoviral vectors that encode drug-metabolizing enzymes: application for drug hepatotoxicity testing

Gomez-Lechon, MJ, Tolosa, L, Donato, MT

Review. 10.1080/17425255.2017.1238459. 2017


Using high-content screening technology for studying drug-induced hepatotoxicity in preclinical studies

Donato, MT, Gomez-Lechon, MJ, Tolosa, L

Review. 10.1080/17460441.2017.1271784. 2017


Ensayo Multiparamétrico In Vitro Para La Evaluación De La Hepatotoxicidad Mitocondrial De Fármacos

Autor/es: Antonio Carmona Serrano

Proyecto Fin de Carrera

Director/s: LAIA TOLOSA PARDO; MARÍA JOSÉ GÓMEZ-LECHÓN MOLINER


Compartir el projecte